Stock Under $10 with 50-100% upside potential - 14 Days FREE!

David Sterman

RealMoney Contributor

David Sterman has been an equity analyst and financial journalist for 15 years, most recently serving as Director of Research at Jesup & Lamont Securities.

David Sterman
By This Author:
« Back
Page 1 of 24
Article

Equity Deals Could Heat Up Rivalries (RealMoney.com $)

By David Sterman

A flurry of capital raises highlights the changing outlook for a number of industries.

03:59PM 05/12/09

Article

Beyond the Lede: Playing the Economic Data (RealMoney.com $)

By David Sterman

Changing monthly data portend a shift for staffers and shippers, and the rig-cutting cycle nears an end.

02:30PM 05/11/09

Article

A Brutal Month for Shorts (RealMoney.com $)

By David Sterman

But if the rally cools, some of these ideas may move still lower.

10:03AM 05/08/09

Article

Ford May Offer a Bumpy Ride Higher (RealMoney.com $)

By David Sterman

The newly appreciated stock will have to contend with the industry's inventory issues.

02:29PM 05/06/09

Article

Kindle Could Singe Barnes & Noble (RealMoney.com $)

By David Sterman

The e-reader has only a fringe following, but it could slow the bookseller's rebound.

12:05PM 05/05/09

Article

Beyond the Lede: Celgene Takes Its Knocks (RealMoney.com $)

By David Sterman

The company leaves its Revlimid target set too high, setting it up for disappointment.

01:31PM 05/04/09

Article

ScreenShot: The Hunt for Low P/Es (RealMoney.com $)

By David Sterman

Although they're getting harder to find, there are still cheap stocks heading to the upside.

01:16PM 05/01/09

Article

A Sneak Peek at Second-Quarter GDP (RealMoney.com $)

By David Sterman

The coming economic calendar will give clues to a possible snapback in the economy.

02:59PM 04/29/09

Article

First Solar Pulls Away From the Pack (RealMoney.com $)

By David Sterman

Be careful, though - the company's mergers and partnerships come with risk.

02:46PM 04/28/09

Article

No Surprises From Bristol-Myers Squibb (RealMoney.com $)

By David Sterman

The focus was on new drugs under development and bringing them to market.

01:05PM 04/28/09

« Back
Page 1 of 24

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.023% -0.003

Brokerage Partners

Advertising Partners

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.

Top Rated Stocks Top Rated Funds Top Rated ETFs